You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Flavoxate hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for flavoxate hydrochloride and what is the scope of freedom to operate?

Flavoxate hydrochloride is the generic ingredient in two branded drugs marketed by Epic Pharma, Impax Pharms, Paddock Llc, and Ortho Mcneil Janssen, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for flavoxate hydrochloride. Four suppliers are listed for this compound.

Summary for flavoxate hydrochloride
Recent Clinical Trials for flavoxate hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

University of CalgaryPhase 4
Mahidol UniversityPhase 4
Paddock Laboratories, Inc.Phase 1

See all flavoxate hydrochloride clinical trials

Pharmacology for flavoxate hydrochloride
Medical Subject Heading (MeSH) Categories for flavoxate hydrochloride

US Patents and Regulatory Information for flavoxate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Janssen URISPAS flavoxate hydrochloride TABLET;ORAL 016769-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Pharms FLAVOXATE HYDROCHLORIDE flavoxate hydrochloride TABLET;ORAL 076234-001 Aug 28, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Epic Pharma FLAVOXATE HYDROCHLORIDE flavoxate hydrochloride TABLET;ORAL 076835-001 Nov 30, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Paddock Llc FLAVOXATE HYDROCHLORIDE flavoxate hydrochloride TABLET;ORAL 076831-001 Dec 16, 2004 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.